AQR Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $479K | Sell |
49,924
-57,475
| -54% | -$551K | ﹤0.01% | 2634 |
|
|
2025
Q1 | $673K | Buy |
107,399
+89,741
| +508% | +$563K | ﹤0.01% | 2253 |
|
|
2024
Q4 | $143K | Buy |
+17,658
| New | +$143K | ﹤0.01% | 2722 |
|
|
2024
Q1 | – | Sell |
-18,427
| Closed | -$168K | – | 2481 |
|
|
2023
Q4 | $168K | Sell |
18,427
-4,408
| -19% | -$40.2K | ﹤0.01% | 2237 |
|
|
2023
Q3 | $237K | Buy |
+22,835
| New | +$237K | ﹤0.01% | 2089 |
|
|
2023
Q1 | – | Sell |
-10,046
| Closed | -$113K | – | 2233 |
|
|
2022
Q4 | $113K | Buy |
+10,046
| New | +$113K | ﹤0.01% | 2131 |
|